Article Text

Download PDFPDF
A review of eGFR reporting after 6 months in practice
  1. A Kremmyda,
  2. W D Neithercut
  1. Department of Clinical Biochemistry, Wirral University Teaching Hospital NHS Foundation Trust, Arrowe Park Hospital, Upton, Wirral, UK
  1. Dr William D Neithercut, Department of Clinical Biochemistry, Wirral University Teaching Hospital NHS Foundation Trust, Arrowe Park Hospital, Upton, Wirral CH49 5PE, UK; duncan.neithercut{at}whnt.nhs.uk

Abstract

Background: Following the introduction of routine calculation of estimated glomerular filtration rate (eGFR) from all serum creatinine values in samples received from general practice it was noted that there was a preponderance of values consistent with chronic kidney disease (CKD) stage 3 or higher.

Methods: A review was conducted of all eGFR values from 51 314 individuals received from primary care during October 2006 to April 2007.

Results: It was found that more than 25% of eGFR results indicated CKD stage 3 or higher. The median age in this group was 64 years (range 18–104 years) while that of the local general population according to the 2001 census was 40 years (range 18–104 years); these ages were statistically significantly different (p<0.001). There was no difference between the groups with regard to gender. The eGFR data were therefore corrected for age distribution, and an estimated prevalence of 5.6% of eGFR consistent with CKD stage 3 was found. This was a higher proportion than estimates of CKD suggested before the introduction of eGFR.

Conclusions: The higher proportion of CKD stage 3 may be due to difference in age and gender in populations studied, as there is a marked effect of age on calculated eGFR values found.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests: None.